Nevada PSE bill
This article was originally published in The Tan Sheet
Executive Summary
State lawmakers Feb. 22 introduced A.B. 150 to limit the diversion of pseudoephedrine-containing OTC medicines to methamphetamine production by requiring prescriptions for the products, along with those made with ephedrine and phenylpropanolamine. The Consumer Healthcare Products Association strongly opposes the bill and will express its concerns in Nevada the week of Feb. 26. The bill is modeled after a 2005 Oregon law (1"The Tan Sheet" Aug. 22, 2005, p. 5). The Bush administration has said it will monitor the effectiveness of behind-the counter provisions of the federal Combat Meth Act as well as stricter state strategies (2"The Tan Sheet" June 12, 2006, p. 6)...